D Shankar1, A M V Kumar2, B Rewari3, S Kumar4, S Shastri5, S Satyanarayana2, R Ananthakrishnan6, S B Nagaraja7, M Devi1, N Bhargava1, M Das8, R Zachariah8. 1. Antiretroviral Treatment Centre (ART), District Hospital, Tumkur, Karnataka, India. 2. International Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office, New Delhi, India. 3. National AIDS Control Organization, New Delhi, India. 4. National AIDS Control Organization, New Delhi, India ; Karnataka State AIDS Prevention Society, Bengaluru, India. 5. Lady Willingdon State TB Centre, Bengaluru, India. 6. Resource Group for Education and Advocacy for Community Health (REACH), Chennai, India. 7. Employees' State Insurance Corporation (ESIC) Medical College and Post Graduate Institute of Medical Sciences & Research (PGIMSR), Bengaluru, India. 8. Médecins Sans Frontières, Operational Centre Brussels, Luxembourg.
Abstract
SETTING: Antiretroviral treatment (ART) Centre in Tumkur district of Karnataka State, India. There is no published information about pre-ART loss to follow-up from India. OBJECTIVE: To assess the proportion lost to follow-up (defined as not visiting the ART Centre within 1 year of registration) and associated socio-demographic and immunological variables. DESIGN: Retrospective cohort study involving a review of medical records of adult HIV-infected persons (aged ⩾15 years) registered in pre-ART care during January 2010-June 2012. RESULTS: Of 3238 patients registered, 2519 (78%) were eligible for ART, while 719 (22%) were not. Four of the latter were transferred out; the remaining 715 individuals were enrolled in pre-ART care, of whom 290 (41%) were lost to follow-up. Factors associated with loss to follow-up on multivariate analysis included age group ⩾45 years, low educational level, not being married, World Health Organization Stage III or IV and rural residence. CONCLUSION: About four in 10 individuals in pre-ART care were lost to follow-up within 1 year of registration. This needs urgent attention. Routine cohort analysis in the national programme should include those in pre-ART care to enable improved review, monitoring and supervision. Further qualitative research to ascertain reasons for loss to follow-up is required to design future interventions.
SETTING: Antiretroviral treatment (ART) Centre in Tumkur district of Karnataka State, India. There is no published information about pre-ART loss to follow-up from India. OBJECTIVE: To assess the proportion lost to follow-up (defined as not visiting the ART Centre within 1 year of registration) and associated socio-demographic and immunological variables. DESIGN: Retrospective cohort study involving a review of medical records of adult HIV-infectedpersons (aged ⩾15 years) registered in pre-ART care during January 2010-June 2012. RESULTS: Of 3238 patients registered, 2519 (78%) were eligible for ART, while 719 (22%) were not. Four of the latter were transferred out; the remaining 715 individuals were enrolled in pre-ART care, of whom 290 (41%) were lost to follow-up. Factors associated with loss to follow-up on multivariate analysis included age group ⩾45 years, low educational level, not being married, World Health Organization Stage III or IV and rural residence. CONCLUSION: About four in 10 individuals in pre-ART care were lost to follow-up within 1 year of registration. This needs urgent attention. Routine cohort analysis in the national programme should include those in pre-ART care to enable improved review, monitoring and supervision. Further qualitative research to ascertain reasons for loss to follow-up is required to design future interventions.
Entities:
Keywords:
ART centre; India; NACP; loss to follow-up; operational research; pre-ART
Authors: M Edginton; D Enarson; R Zachariah; T Reid; S Satyanarayana; K Bissell; S G Hinderaker; T Harries Journal: Public Health Action Date: 2012-03-21
Authors: Elvin H Geng; David V Glidden; Nneka Emenyonu; Nicolas Musinguzi; Mwebwesa Bosco Bwana; Torsten B Neilands; Winnie Muyindike; Constantin T Yiannoutsos; Steven G Deeks; David R Bangsberg; Jeffrey N Martin Journal: Trop Med Int Health Date: 2010-06 Impact factor: 2.622
Authors: Elvin H Geng; Denis Nash; Andrew Kambugu; Yao Zhang; Paula Braitstein; Katerina A Christopoulos; Winnie Muyindike; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; Maya L Petersen; Jeffrey N Martin Journal: Curr HIV/AIDS Rep Date: 2010-11 Impact factor: 5.071
Authors: Elvin H Geng; David V Glidden; Mwebesa Bosco Bwana; Nicolas Musinguzi; Nneka Emenyonu; Winnie Muyindike; Katerina A Christopoulos; Torsten B Neilands; Constantin T Yiannoutsos; Steven G Deeks; David R Bangsberg; Jeffrey N Martin Journal: PLoS One Date: 2011-07-26 Impact factor: 3.240
Authors: Benjamin H Chi; Constantin T Yiannoutsos; Andrew O Westfall; Jamie E Newman; Jialun Zhou; Carina Cesar; Martin W G Brinkhof; Albert Mwango; Eric Balestre; Gabriela Carriquiry; Thira Sirisanthana; Henri Mukumbi; Jeffrey N Martin; Anna Grimsrud; Melanie Bacon; Rodolphe Thiebaut Journal: PLoS Med Date: 2011-10-25 Impact factor: 11.069
Authors: Jared Perlo; Isabella Colocci; Sai Shanthanand Rajagopal; Theresa S Betancourt; Amrose Pradeep; Kenneth H Mayer; Nagalingeswaran Kumarasamy; Conall O'Cleirigh; Brian T Chan Journal: J Int Assoc Provid AIDS Care Date: 2020 Jan-Dec
Authors: S Chawla; K Shringarpure; B Modi; R Sharma; B B Rewari; A N Shah; P B Verma; A R Dongre; A M V Kumar Journal: Public Health Action Date: 2017-09-21